|1.||Yokozawa, Takako: 6 articles (06/2015 - 08/2010)|
|2.||Park, Chan Hum: 6 articles (06/2015 - 08/2010)|
|3.||Tanaka, Takashi: 6 articles (06/2015 - 08/2010)|
|4.||Noh, Jeong Sook: 3 articles (12/2012 - 08/2010)|
|5.||Lee, Chan Mee: 1 article (06/2015)|
|6.||Jung, Hyun Ah: 1 article (06/2015)|
|7.||Choi, Jae Sue: 1 article (06/2015)|
|8.||Oh, Sang Ho: 1 article (06/2015)|
|9.||Shibahara, Naotoshi: 1 article (01/2012)|
|10.||Park, Jong Cheol: 1 article (01/2012)|
01/01/2012 - "The present study was conducted to examine whether 7-O-galloyl-D-sedoheptulose (GS) has an ameliorative effect on diabetic alterations such as oxidative stress, inflammation, and apoptosis in the liver of type 2 diabetic db/db mice. "
08/25/2010 - "The aim of the present study was to evaluate the beneficial effects of 7-O-galloyl-D-sedoheptulose (GS), isolated from Corni Fructus, on hepatic and renal lipid metabolisms and advanced glycation endproduct formation followed by oxidative stress and inflammation using type 2 diabetic mice. "
01/01/2013 - "Anti-diabetic action of 7-O-galloyl-D-sedoheptulose, a polyphenol from Corni Fructus, through ameliorating inflammation and inflammation-related oxidative stress in the pancreas of type 2 diabetics."
12/01/2012 - "7-O-galloyl-D-sedoheptulose ameliorates renal damage triggered by reactive oxygen species-sensitive pathway of inflammation and apoptosis."
08/01/2010 - "These findings led us to conclude that morroniside, loganin, and 7-O-galloyl-D-sedoheptulose would synergistically contribute to the inhibition of metabolic disorders (hyperglycemia and dyslipidemia), oxidative stress, inflammation, as well as AGE formation in the diabetic kidney."
06/01/2015 - "Our results clearly indicate that loganin and 7-O-galloyl-D-sedoheptulose have great promise for the treatment of diabetic complications through inhibition of AR. "
06/01/2015 - "In this study, we evaluated whether two major compounds of Corni Fructus, loganin and 7-O-galloyl-D-sedoheptulose, had an inhibitory effect on diabetic complications through AR inhibition. "
06/01/2015 - "Because the iridoid glycoside loganin and the low-molecular-weight polyphenol 7-O-galloyl-D-sedoheptulose showed marginal inhibitory activities against rat lens AR (RLAR) and human recombinant AR (HRAR) in inhibition assays, we performed enzyme kinetic analyses and molecular simulation of the interaction of these two compounds with AR to further investigate their potential as inhibitors of diabetic complications. "
06/01/2015 - "Kinetic and molecular docking studies of loganin and 7-O-galloyl-D-sedoheptulose from Corni Fructus as therapeutic agents for diabetic complications through inhibition of aldose reductase."
|3.||Acute Kidney Injury (Acute Renal Failure)
|2.||Reactive Oxygen Species (Oxygen Radicals)
|3.||Aldehyde Reductase (Aldose Reductase)